Prospective assessment of genitourinary (GU) and gastrointestinal (GI) toxicity of post-operative radiotherapy (RT) to the prostate bed following radical prostatectomy (RP) for pathologic T3 (PT3) and/or positive surgical margins

被引：0
|
作者：
Choo, R.
Pearse, M.
Danjoux, C.
Gardner, S.
Morton, G.
Szumacher, E.
Barak, I.
Loblaw, A.
Cheung, P.
机构：
[1] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
[2] Univ Toronto, Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 80卷
关键词：
D O I：
10.1016/S0167-8140(06)80949-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
208
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 14 条
  • [1] Prospective evaluation of acute and late genitourinary (GU) and gastrointestinal (GI) toxicity of postoperative radiotherapy (RT) to the prostate bed for patients with pathologic T3 (PT3) and/or positive surgical margins after radical prostatectomy (RP)
    Choo, R.
    Pearse, M.
    Danjoux, C.
    Gardner, S.
    Morton, G.
    Szumacher, E.
    Barak, I.
    Loblaw, A.
    Cheung, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S369 - S370
  • [2] Prospective evaluation of gastrointestinal (GI) and genitourinary (GU) toxicity of salvage radiotherapy (RT) to the prostate bed for patients with PSA relapse after radical prostatectomy (RP)
    Pearse, M.
    Choo, R.
    Danjoux, C.
    Gardner, S.
    Morton, G.
    Szumacher, E.
    Loblaw, A.
    Cheung, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S348 - S348
  • [3] PROSPECTIVE EVALUATION OF GASTROINTESTINAL (GI) AND GENITOURINARY (GU) TOXICITY OF SALVAGE RADIOTHERAPY (RT) TO THE PROSTATE BED FOR PATIENTS WITH PSA RELAPSE AFTER RADICAL PROSTATECTOMY (RP)
    Choo, R.
    Pearse, M.
    Danjoux, C.
    Gardner, S.
    Morton, G.
    Szumacher, E.
    Loblaw, A.
    Cheung, P.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S32 - S32
  • [4] PHASE II STUDY EVALUATING POST-OPERATIVE RADIOTHERAPY (RT) PLUS 2-YEAR ANDROGEN SUPPRESSION ( AS) FOR POST-RADICAL PROSTATECTOMY PATIENTS WITH PT3 AND/OR POSITIVE SURGICAL MARGINS
    Choo, R.
    Danjoux, C.
    Gardner, S.
    Morton, G.
    Szumacher, E.
    Loblaw, A.
    Cheung, P.
    Pesrse, M.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S9 - S10
  • [5] ANALYSIS OF GASTROINTESTINAL AND GENITOURINARY MORBIDITY OF POSTOPERATIVE RADIOTHERAPY FOR PATHOLOGIC T3 DISEASE OR POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY USING NATIONAL CANCER INSTITUTE EXPANDED COMMON TOXICITY CRITERIA
    Choo, Richard
    Pearse, Maria
    Danjoux, Cyril
    Gardner, Sandra
    Morton, Gerard
    Szumacher, Ewa
    Loblaw, D. Andrew
    Cheung, Patrick
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (04): : 989 - 995
  • [6] Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with PT3 and/or positive surgical margins
    Choo, R.
    Danjoux, C.
    Gardner, S.
    Morton, G.
    Szumacher, E.
    Loblaw, A.
    Cheung, P.
    Pcarse, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S307 - S308
  • [7] PROSPECTIVE STUDY EVALUATING POSTOPERATIVE RADIOTHERAPY PLUS 2-YEAR ANDROGEN SUPPRESSION FOR POST-RADICAL PROSTATECTOMY PATIENTS WITH PATHOLOGIC T3 DISEASE AND/OR POSITIVE SURGICAL MARGINS
    Choo, Richard
    Danjoux, Cyril
    Gardner, Sandra
    Morton, Gerard
    Szumacher, Ewa
    Loblaw, D. Andrew
    Cheung, Patrick
    Pearse, Maria
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 407 - 412
  • [8] Comparison between surveillance, adjuvant radiotherapy, or salvage radiotherapy after radical prostatectomy in patients with prostate cancer (PCa) in stage pT3 or higher and/or positive surgical margins
    Rodriguez-Covarrubias, Francisco
    Sotomayor-de-Zavaleta, Mariano
    Castillejos-Molina, Ricardo
    Gabilondo-Navarro, Fernando
    Feria-Bernal, Guillermo
    GACETA MEDICA DE MEXICO, 2014, 150 : 140 - 144
  • [9] Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: A systematic review and meta-analysis
    Morgan, Scott C.
    Waldron, Tricia S.
    Eapen, Libni
    Mayhew, Linda A.
    Winquist, Eric
    Lukka, Himu
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 (01) : 1 - 9
  • [10] Does the Benefit of Adjuvant Radiotherapy following Radical Prostatectomy for Pathologic T3 or Margin-positive Prostate Cancer Extend to All Pathologic Subgroups? A Meta-analysis of the Randomized Trials
    Morgan, S. C.
    Walker-Dilks, C.
    Goldman, B.
    Eapen, L. J.
    Winquist, E. W.
    Chin, J. L.
    Swanson, G. P.
    Thompson, I. M.
    Loblaw, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S29 - S30
12